Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study

Author:

de la Asunción Carlos Solano1,Giménez Estela12,Hernández‐Boluda Juan Carlos3,Terol María José34,Albert Eliseo1,López Javier5,García‐Gutiérrez Valentín5,Andreu Rafael6,Malo María Dolores García7,Fox María Laura8,Remigia María José3,Amat Paula3,Solano Carlos34,Navarro David129ORCID

Affiliation:

1. Microbiology Service, INCLIVA Research Institute Hospital Clínico Universitario Valencia Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) Instituto de Salud Carlos III Madrid Spain

3. Hematology Service, INCLIVA Research Institute Hospital Clínico Universitario Valencia Spain

4. Department of Medicine, School of Medicine University of Valencia Valencia Spain

5. Hematology Service Hospital Universitario Ramón y Cajal Madrid Spain

6. Hematology Service Hospital Universitario Politécnico “La Fe” Valencia Spain

7. Hematology Service Hospital Morales Meseguer Murcia Spain

8. Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari Vall d'Hebron Barcelona Hospital Campus Barcelona Spain

9. Department of Microbiology, School of Medicine University of Valencia Valencia Spain

Abstract

AbstractIt is unknown whether Torque Teno virus (TTV) DNA load monitoring could anticipate the development of infectious events in hematological patients undergoing treatment with small molecular targeting agents. We characterized the kinetics of plasma TTV DNA in patients treated with ibrutinib or ruxolitinib and assessed whether TTV DNA load monitoring could predict the occurrence of Cytomegalovirus (CMV) DNAemia or the magnitude of CMV‐specific T‐cell responses. Multicenter, retrospective, observational study, recruiting 20 patients treated with ibrutinib and 21 with ruxolitinib. Plasma TTV and CMV DNA loads were quantified by real‐time PCR at baseline and days +15, +30, +45, +60, +75, +90, +120, +150, and +180 after treatment inception. Enumeration of CMV‐specific interferon‐γ (IFN‐γ)‐producing CD8+ and CD4+ T‐cells in whole blood was performed by flow cytometry. Median TTV DNA load in ibrutinib‐treated patients increased significantly (p = 0.025) from baseline (median: 5.76 log10 copies/mL) to day +120 (median: 7.83 log10 copies/mL). A moderate inverse correlation (Rho = −0.46; p < 0.001) was found between TTV DNA load and absolute lymphocyte count. In ruxolitinib‐treated patients, TTV DNA load quantified at baseline was not significantly different from that measured after treatment inception (p ≥ 0.12). TTV DNA load was not predictive of the subsequent occurrence of CMV DNAemia in either patient group. No correlation was observed between TTV DNA loads and CMV‐specific IFN‐γ‐producing CD8+ and CD4+ T‐cell counts in either patient group. The data did not support the hypothesis that TTV DNA load monitoring in hematological patients treated with ibrutinib or ruxolitinib could be useful to predict either the occurrence of CMV DNAemia or the level of CMV‐specific T‐cell reconstitution; nevertheless, due to the small sample size, further studies involving larger cohorts are warranted to elucidate this issue.

Publisher

Wiley

Subject

Infectious Diseases,Virology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3